BioNTech SE (BNTX) Current Assets (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Current Assets data on file, last reported at $18.8 billion in Q4 2025.

• In Q4 2025, Current Assets fell 6.46% year-over-year to $18.8 billion; the TTM figure through Dec 2025 stood at $18.8 billion (down 6.46% YoY), while the FY2025 annual figure was $18.2 billion, down 9.21% from the prior year.
• Current Assets grew to $18.8 billion in Q4 2025, from $18.5 billion in the prior quarter.
• Across five years, Current Assets topped out at $22.4 billion in Q4 2022 and bottomed at $4.3 billion in Q1 2021.
• A 5-year average of $18.5 billion and a median of $20.0 billion in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2021 — Current Assets jumped 1385.59% — and 2025, when it fell 17.21%.
• Year by year, Current Assets stood at $17.2 billion in 2021, then increased by 29.72% to $22.4 billion in 2022, then dropped by 6.06% to $21.0 billion in 2023, then declined by 4.36% to $20.1 billion in 2024, then decreased by 6.46% to $18.8 billion in 2025.
• The last three Current Assets figures came in at $18.8 billion (Q4 2025), $18.5 billion (Q3 2025), and $18.0 billion (Q2 2025), per Business Quant data.

Peer Comparison